Century Therapeutics (IPSC)
(Delayed Data from NSDQ)
$1.54 USD
+0.08 (5.48%)
Updated Sep 9, 2024 04:00 PM ET
After-Market: $1.54 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -0.46 |
EPS Last Quarter | -0.38 |
Last EPS Surprise | 24.00% |
ABR | 1.25 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.80 |
Next Year | -1.89 |
EPS (TTM) | -1.87 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.47M | 0.47M | 2.64M | 3.13M |
# of Estimates | 3 | 3 | 3 | 3 |
High Estimate | 1.00M | 1.00M | 3.86M | 5.00M |
Low Estimate | 0.10M | 0.10M | 1.83M | 0.40M |
Year ago Sales | 0.15M | 0.27M | 2.23M | 2.64M |
Year over Year Growth Est. | 210.67% | 72.59% | 18.12% | 18.67% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.46 | -0.50 | -1.80 | -1.89 |
# of Estimates | 3 | 3 | 5 | 5 |
Most Recent Consensus | -0.41 | -0.47 | -1.71 | -1.93 |
High Estimate | -0.41 | -0.47 | -1.71 | -1.42 |
Low Estimate | -0.51 | -0.53 | -1.88 | -2.22 |
Year ago EPS | -0.55 | -0.49 | -2.08 | -1.80 |
Year over Year Growth Est. | 16.36% | -2.04% | 13.46% | -5.22% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 2 | 2 | 2 | 2 |
Up Last 60 Days | 2 | 2 | 2 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 1 | 1 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.46 | -0.50 | -1.80 | -1.89 |
7 Days Ago | -0.46 | -0.50 | -1.80 | -1.89 |
30 Days Ago | -0.51 | -0.53 | -1.92 | -1.93 |
60 Days Ago | -0.51 | -0.53 | -1.94 | -1.97 |
90 Days Ago | -0.51 | -0.53 | -1.94 | -1.97 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.46 | -0.50 | -1.80 | -2.08 |
Zacks Consensus Estimate | -0.46 | -0.50 | -1.80 | -1.89 |
Earnings ESP | 0.00% | 0.00% | 0.00% | -10.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.38 | -0.45 | -0.49 | -0.55 | NA |
Estimate | -0.50 | -0.50 | -0.56 | -0.53 | NA |
Difference | 0.12 | 0.05 | 0.07 | -0.02 | 0.06 |
Surprise | 24.00% | 10.00% | 12.50% | -3.77% | 10.68% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more